Home Newsfeeds Argus Research Downgrades Bath & Body Works to Hold

Argus Research Downgrades Bath & Body Works to Hold

Argus Research analyst Taylor Conrad downgrades Bath & Body Works (NYSE:BBWI) from Buy to Hold.

byBenzinga Newsdesk

March 17, 2023

1 minute read

Argus Research analyst Taylor Conrad downgrades Bath & Body Works (NYSE:BBWI) from Buy to Hold.

$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,900 Today

By Benzinga Insights

August 2, 2:42 PM

Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 7.89% on an annualized basis producing an average annual return of 19.21%. Currently, Morgan Stanley has a market capitalization of $144.77 billion.

AbbVie Announces Phase 3 SELECT-GCA Study Of Upadacitinib Results In Patients With Giant Cell Arteritis; In Combination With A 26-week Steroid Taper Regimen Achieved Its Primary Endpoint Of Sustained Remission; Key Secondary Endpoints Were Also Met

By Benzinga Newsdesk

April 18, 8:32 AM

− Results from the Phase 3 SELECT-GCA study showed 46 percent of patients with giant cell arteritis (GCA) who were treated with upadacitinib (RINVOQ®; 15 mg) with a 26-week steroid taper

ABBV